A University of Manitoba-led study has successfully eliminated breast-cancer-derived brain tumors in mice, using a drug to ...

Drugs and other treatments can be quite ... Working in a mouse model of triple-negative breast cancer, the researchers used their approach to slow tumor growth far more than treatment with ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...

Telomir-1 reduced tumor size by 50% in a prostate cancer model and protected against chemotherapy ... tumor development…We are seeing a drug that extends cellular health while simultaneously ...

Each patient’s cancer is a unique mosaic of genetic ... forward both with a synergistic diagnostic and a drug development model. You can do that when you have a company built on experience ...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

These effects ultimately lead to improved efficacy in treating solid tumors ... The drug screening platform can assess FDA-approved small molecules using the CAR-T cell exhaustion model.

Contrary to concerns that telomere-elongating drugs may promote cancer, Telomir-1 demonstrated the opposite effect—actively suppressing tumor development, while selectively benefiting healthy cells.

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.